• Tofacitinib (CP-690550) in Immune Cell Assays: Workflows & I

  2026-07-22

  Tofacitinib (CP-690550) stands out as a JAK1/JAK3 selective inhibitor, uniquely reversing both inflammatory and mitochondrial dysfunctions in immune modulation research. Leverage this powerful tool to dissect cytokine signaling and metabolic reprogramming in RA models, with evidence-based protocols and troubleshooting tips for reproducible, high-impact results.

• Venetoclax (ABT-199): Mechanistic Insights and Translational

  2026-07-21

  Explore how selective Bcl-2 inhibition with ABT-199 (Venetoclax) unlocks new avenues for apoptosis research, with a focus on mechanistic depth, protocol optimization, and strategic translation in hematologic malignancy models.

• Reliable ROS Quantification with the Reactive Oxygen Species

  2026-07-21

  Biomedical researchers require reproducible, quantitative assays to measure oxidative stress in live cells. This article explores real-world laboratory challenges and demonstrates how the Reactive Oxygen Species Assay Kit (SKU K2065) leverages the DCFH-DA fluorescent probe for reliable, sensitive detection. Evidence-based scenario Q&A blocks clarify protocol optimization, data interpretation, and vendor selection, providing practical insights for oxidative stress research.

• Guanabenz Acetate: Advanced Strategies for Stress Response A

  2026-07-20

  Explore how Guanabenz Acetate, a selective α2-adrenergic receptor agonist, enables precise dissection of integrated stress response and innate immunity in cell-based research. This cornerstone review delivers new experimental insights and strategic recommendations for leveraging Guanabenz Acetate in advanced GPCR signaling and antiviral assay workflows.

• Applied Use of KN-62: Precision CaMKII Inhibition in Cellula

  2026-07-20

  KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, delivers unmatched selectivity for dissecting CaMKII-mediated calcium signaling, cell cycle regulation, and metabolic pathways. This article translates cutting-edge findings and field-proven protocols into actionable workflows and troubleshooting strategies for maximizing experimental rigor with APExBIO’s KN-62.

• Albiflorin Suppresses RCC Progression via EGFR/MAPK Pathway

  2026-07-19

  This study integrates experimental and network pharmacology approaches to demonstrate that albiflorin, a compound from Paeonia lactiflora, inhibits renal cell carcinoma (RCC) cell proliferation and migration by targeting EGFR/MAPK signaling. Findings provide mechanistic insights into albiflorin's multi-target anti-tumor effects and highlight new candidate pathways for RCC intervention.

• Mechanistic DDI Risks for Oteseconazole: 2022 FDA Insights

  2026-07-18

  A comprehensive review of new molecular entities approved by the FDA in 2022 reveals mechanistic drug-drug interaction (DDI) risks, especially for agents like Oteseconazole (VT-1161). The study offers nuanced guidance on enzyme and transporter interactions, shaping safe antifungal use in complex patient populations.

• Intestinal TM6SF2 Protects Against MASH via the Gut–Liver Ax

  2026-07-17

  This study uncovers a critical protective role for intestinal TM6SF2 in metabolic dysfunction-associated steatohepatitis (MASH), demonstrating how its deficiency disrupts gut barrier integrity and microbiota, leading to liver inflammation. The findings establish the gut–liver axis as a mechanistic link in MASH progression and highlight new intervention strategies targeting host–microbe interactions and lipid signaling.

• Phosphotungstic Acid Negative Stain (2%): Enabling Precision

  2026-07-17

  Explore how Phosphotungstic Acid Negative Stain Solution (2%) empowers high-contrast electron microscopy for advanced viral glycan analysis. This article uniquely bridges practical assay optimization with breakthrough insights from coronavirus entry research.

• Selective P2X1 Blockade: NF449 and Platelet Function Modulat

  2026-07-16

  The reference study demonstrates that NF449 is a highly selective antagonist of the platelet P2X1 receptor, providing crucial insights into the discrete roles of P2 receptor subtypes in platelet activation and thrombosis. These findings advance the understanding of targeted antithrombotic strategies and inform the design of platelet inhibition assays in blood coagulation research.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Use Guide

  2026-07-16

  The PKH26 Red Fluorescent Cell Linker Kit addresses the need for stable, membrane-specific fluorescent labeling in cell biology research, enabling robust cell tracing and division tracking in vitro and in vivo. It is not intended for intracellular or non-membrane applications; protocol adherence is critical for optimal results.

• Dasatinib Monohydrate (BMS-354825): Reliable Kinase Inhibito

  2026-07-15

  This article addresses practical laboratory challenges in cell viability and kinase inhibition workflows, providing scenario-driven insights into how Dasatinib Monohydrate (SKU B5954) supports reproducible, sensitive, and translationally relevant data generation for CML and related models. Evidence-backed comparisons and protocol guidance help researchers leverage its advantages for robust experimental outcomes.

• Tetrandrine Alkaloid: Mechanistic Insight and Translational

  2026-07-15

  Explore how Tetrandrine, a plant-derived calcium channel modulator, is reshaping translational research across neuroscience, cancer biology, and inflammation. This article blends mechanistic detail with strategic guidance, examining how APExBIO's Tetrandrine optimizes ion channel modulation studies and bridges rigorous bench science to clinical promise. Drawing on peer-reviewed evidence and expert protocols, we chart a course from molecular understanding to translational impact.

• Protoporphyrin IX: Precision Tool for Photodynamic Cancer As

  2026-07-14

  Explore Protoporphyrin IX as a photodynamic compound in advanced cancer diagnostics and therapy. This article uniquely examines its assay performance, protocol design, and the impact of iron metabolism, offering deeper technical insight for translational researchers.

• 2-Hydroxypropyl-β-cyclodextrin: Practical Use in Solubility

  2026-07-14

  2-Hydroxypropyl-β-cyclodextrin addresses the persistent challenge of dissolving poorly water-soluble, hydrophobic compounds—especially those with aromatic or phenyl groups—by forming aqueous inclusion complexes. Its use is validated for pharmaceutical and biochemical research workflows focused on solubility and formulation improvement; applications beyond these contexts are not supported by current product documentation.

458 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page